Chemical Mediators 3 Flashcards
What is the endocrine system?
It’s a network of glands and hormones which is important in regulating metabolism, growth and reproduction
Relies upon rapid nerve impulses and it uses chemicals for long-term regulation
Parts of the endocrine system
Pituitary Gland: Often termed the ‘master gland’; controls other endocrine glands.
Thyroid Gland: Regulates metabolism, energy generation, and growth.
Parathyroid Glands: Crucial for calcium balance in the body.
Adrenal Glands: Produce hormones like adrenaline and cortisol, essential for stress response.
Pancreas: Key in glucose regulation; produces insulin and glucagon.
Gonads (Ovaries/Testes): Responsible for producing sex hormones and gametes.
What is serotonin (5-hydroxytryptamine) ?
-neurotransmitter in the brain and periphery
-acts as a local hormone in the peripheral vascular system
-shown to be originated from platelets
-formed from dietary tryptophan; chocolate, oats etc
Where can 5-HT be found in the body?
-in the gut, 90% of the total amount is in the intestine, enterchhromaffin cells and some in enteric neurones of the intestine
-in the blood; platelets
-in the CNS
More about 5-HT;
Where does endogenous 5-HT arise from?
-most 5-HT is present in the diet however most of this is metabolised before entering the bloodstream
-arises from a biosyntehtic pathway similar to that which generates noradrenaline, except that precursor amino acid; tryptophan instead of tyrosine
Distribution and biosynthesis of tryptophan?
• Tryptophan is converted to 5- hydroxytryptophan (in chromaffin cells and neurones, but not in platelets) by the action of tryptophan hydroxylase.
• The 5-hydroxytryptophan is then decarboxylated to 5-HT by a ubiquitous amino acid decarboxylase that also participates in the synthesis of catecholamines and histamine
- platelets posses a high affinity 5-HT uptake mechanism and platelets become loaded with 5-HT as they pass through the intestinal circulation; where the local conc is high
Distribution and biosynthesis of tryptophan; continued
-mechanisms of synthesis, storage, release and reuptake of 5-HT are very similar to noradrenaline
-many drugs affect both processes but selective serotonin reuptake inhibitors= been developed and are important therapeutically as antidepressants
-5-HT is stored in neurones and chromaffin cells as a cotransmitter together with various peptide hormones; e.g. somatostatin
Describe the process of the degradation of 5-HT:
-occurs mainly through oxidative deamination, catalysed by monoamine oxidase, followed by oxidation to 5-hydroxyindoleacetic acid pathway (same as noradrenaline catabolism)
-excreted in urine and serves as an indicator of 5-HT production in the body
^ used for stuff like; diagnosis of carcinoid syndrome
Biosynthesis and metabolism of 5-HT
Slide 11
What are the actions + functions of 5-HT?
-increased gastrointestinal motility (direct excitation of
smooth muscle and indirect action via enteric neurones)
– contraction of other smooth muscle (bronchi, uterus)
– mixture of vascular constriction (direct and via
sympathetic innervation) and dilatation (endothelium-
dependent)
– platelet aggregation
– stimulation of peripheral nociceptive nerve endings
– excitation/inhibition of central nervous system
neurones
What does postulated physiological pathophysiological roles include?
in periphery: peristalsis, vomiting, platelet aggregation and haemostasis, inflammatory mediator, sensitisation of nociceptors and microvascular control
in CNS: many postulated functions, including control of appetite, sleep, mood, hallucinations, stereotyped behaviour, pain perception and vomiting.
Clinical conditions associated with disturbed 5-hydroxytryptamine function:
Migraines, carcinoid syndrome, mood disorders and anxiety
Pharmacological effects:
Actions of 5HT is complex (reflects a profusion of 5HT receptor subtypes) and a lot
14 types / subtypes of different receptors
Main sites of action:
Gut
Blood vessels
Platelets
Smooth muscle
Nerve endings
CNS
5-Hydroxytryptamine receptors
Pharmacology lecture 9 chemical mediators 3
Slide 17-19